SAB-301
160119
Phase 1 mab completed
Quick answer
SAB-301 for Middle East Respiratory Syndrome Coronavirus is a Phase 1 program (mab) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SAB Biotherapeutics
- Indication
- Middle East Respiratory Syndrome Coronavirus
- Phase
- Phase 1
- Modality
- mab
- Status
- completed